Lupin sets off Indian pharma's long road to redemption
Hit by bans and sanctions, Indian drugmakers work overtime to satisfy FDA on hygiene, safety standards
Mon, Jul 10, 2017 - 5:50 AM
Lupin is phasing out the practice of making notes in hardbound registers by workers as it transitions to more secure e-files. It also videotapes staff to ensure they follow standard operating procedure.
IN 28 years in India's pharmaceuticals sector, Rajiv Desai has never been busier. Most of the last six months on his desk calendar is marked green, indicating visits to the 12 plants of Lupin, India's No 2 drugmaker, where Mr Desai is a senior quality...